Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Artesunate

EU orphan designation number: EU/3/12/1079   
Active ingredient: Artesunate
Indication: Treatment of malaria
Sponsor: Dafra Pharma International NV
Slachthuisstraat 30/7,B- 2300 Turnhout, BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/12/2012 Centralised Orphan - Designation EMA/OD/123/12 (2012)9398 of 06/12/2012